This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Parexel International Corp (PRXL)

NASDAQ: Health Care

11/24/15 - 3:59:00 PM ET
  • Prev Close: 67.90
  • Avg Vol: 568.90K
  • Shares Outstanding: 53.24M
  • Mkt Cap: 3.62B
  • Div: --
  • Div Yield: --
  • P/E: 28.01
  • EPS: 2.69
PRXL Day's Range
PRXL 52 Week Range
PRXL Business Summary
PAREXEL International Corp, a biopharmaceutical services company, provides clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide.View PRXL key stats
Parexel International Corp - PRXL - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Parexel International Corp as a Buy with a ratings score of B+.
Report Snippet: We rate PAREXEL INTERNATIONAL CORP (PRXL) a BUY. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income.
Rating: 4.0 out of 5, 'B+' Buy.
You can view the full analysis from the report here:
PRXL Rating Report
PRXL Performance as of Prev. Close
PRXL EPS Performance
1-Yr Ago
2-Yrs Ago
3-Yrs Ago
PRXL Percentage in these ETFs

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

PRXL Parexel International Corp

Chart of PRXL

Analysts Ratings for PRXL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 5 5
Moderate Buy 0 0 0 0
Hold 6 6 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

PRXL Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs